Filter Results:
(176)
Show Results For
- All HBS Web (176)
- Faculty Publications (16)
Show Results For
- All HBS Web (176)
- Faculty Publications (16)
- Web
The Global Health Delivery Project - Institute For Strategy And Competitiveness
Delivery Project The Institute for Cancer Care Innovation MOC Network ICIC U.S. Cluster Mapping Project U.S. Competitiveness Project FSG Shared Value Initiative Social Progress... View Details
- 28 May 2012
- Research & Ideas
A Pragmatic Alternative for Creating a Corporate Social Responsibility Strategy
various directions within different departments. For example, human resources might initiate a United Way gift program that involves a company match; operations might work on waste reduction; and marketing might collect an extra dime from... View Details
Keywords: by Dina Gerdeman
- April 2021
- Article
Utilizing Time-driven Activity-based Costing to Determine Open Radical Cystectomy and Ileal Conduit Surgical Episode Cost Drivers
By: Janet Baack Kukreja, Mohamed A. Seif, Marissa W. Merry, James R. Incalcaterra, Ashish M. Kamat, Colin P. Dinney, Jay B. Shah, Thomas W. Feeley and Neema Navai
Objectives
Patients undergoing radical cystectomy represent a particularly resource-intensive patient population. Time-driven activity based costing (TDABC) assigns time to events and then costs are based on the people involved in providing care for specific... View Details
Patients undergoing radical cystectomy represent a particularly resource-intensive patient population. Time-driven activity based costing (TDABC) assigns time to events and then costs are based on the people involved in providing care for specific... View Details
Keywords: Time-Driven Activity-Based Costing; Value-based Healthcare; Health Care and Treatment; Cost; Cost vs Benefits; Analysis
Kukreja, Janet Baack, Mohamed A. Seif, Marissa W. Merry, James R. Incalcaterra, Ashish M. Kamat, Colin P. Dinney, Jay B. Shah, Thomas W. Feeley, and Neema Navai. "Utilizing Time-driven Activity-based Costing to Determine Open Radical Cystectomy and Ileal Conduit Surgical Episode Cost Drivers." Urologic Oncology: Seminars and Original Investigations 39, no. 4 (April 2021).
- 22 Aug 2005
- Research & Ideas
Balancing the Future Against Today’s Needs
wagon wheel factory after the car has been invented.—Alex Urquhart, GE Commercial Finance This has been a critical motivational point for Phanstiel at PacifiCare. When the company unveiled its growth plans... View Details
Keywords: by Paul Michelman
- 16 Aug 2011
- Working Paper Summaries
Managing Political Risk in Global Business: Beiersdorf 1914-1990
- May 2023 (Revised June 2023)
- Case
Novartis (A): Reimagining Medicine
By: Ramon Casadesus-Masanell, Claudio Feser, Karolin Frankenberger and David Redaschi
This case unfolds around the first-ever approved personalized cancer treatment, how Novartis wrapped it into a new business model design, and how Novartis scaled it. Novartis — one of the largest pharmaceutical companies in the world — is, among other ventures,... View Details
Keywords: Health Care and Treatment; Business Model; Leadership; Pharmaceutical Industry; Switzerland
Casadesus-Masanell, Ramon, Claudio Feser, Karolin Frankenberger, and David Redaschi. "Novartis (A): Reimagining Medicine." Harvard Business School Case 723-443, May 2023. (Revised June 2023.)
- May 2023 (Revised June 2023)
- Supplement
Novartis (C): Reimagining Medicine
By: Ramon Casadesus-Masanell, Claudio Feser, Karolin Frankenberger and David Redaschi
This case unfolds around the first-ever approved personalized cancer treatment, how Novartis wrapped it into a new business model design, and how Novartis scaled it. Novartis — one of the largest pharmaceutical companies in the world — is, among other ventures,... View Details
Keywords: Health Testing and Trials; Health Care and Treatment; Business Model; Problems and Challenges; Pharmaceutical Industry; Switzerland
Casadesus-Masanell, Ramon, Claudio Feser, Karolin Frankenberger, and David Redaschi. "Novartis (C): Reimagining Medicine." Harvard Business School Supplement 723-445, May 2023. (Revised June 2023.)
- May 2023 (Revised June 2023)
- Supplement
Novartis (B): Reimagining Medicine
By: Ramon Casadesus-Masanell, Claudio Feser, Karolin Frankenberger and David Redaschi
This case unfolds around the first-ever approved personalized cancer treatment, how Novartis wrapped it into a new business model design, and how Novartis scaled it. Novartis — one of the largest pharmaceutical companies in the world — is, among other ventures,... View Details
Keywords: Health Care and Treatment; Business Model; Production; Business Strategy; Pharmaceutical Industry
Casadesus-Masanell, Ramon, Claudio Feser, Karolin Frankenberger, and David Redaschi. "Novartis (B): Reimagining Medicine." Harvard Business School Supplement 723-444, May 2023. (Revised June 2023.)
- 15 Apr 2014
- First Look
First Look: April 15
Purchase this case: http://hbr.org/product/pepsico-profits-and-food-the-belt-tightens/an/314055-PDF-ENG Harvard Business School Case 313-012 Cancer Treatment Centers of America® (A) Cancer Treatment Centers... View Details
Keywords: Sean Silverthorne
- 06 Sep 2019
- Blog Post
The Business of Medicine: MD/MBA Students Having an Impact
investigation with market research to evaluate access to cancer biopsy devices in East Africa. With her dual degree, Wagner plans to continue her work in health care delivery and her career in improving... View Details
- August 2023
- Case
Constellation Pharmaceuticals: Corporate Development at a Novel Therapeutic Company
By: Satish Tadikonda and Brad Prosek
Constellation Pharmaceuticals was a company focused on epigenetic therapies for cancer patients. Despite a promising start and an early deal with a leading biopharma company, the company weathered twin setbacks in the end of a major research collaboration and the... View Details
Keywords: Mergers and Acquisitions; Health Care and Treatment; Organizational Change and Adaptation; Research and Development; Business Strategy; Partners and Partnerships; Goals and Objectives; Pharmaceutical Industry; United States
Tadikonda, Satish, and Brad Prosek. "Constellation Pharmaceuticals: Corporate Development at a Novel Therapeutic Company." Harvard Business School Case 824-032, August 2023.
- 28 Nov 2005
- Research & Ideas
Unilever: Transformation and Tradition
for major innovations. The science base was high quality and deep. Research on animal feeds could lead over time into a successful pregnancy test. Unilever's knowledge about edible fats and detergents was second to none in the world. This... View Details
- Research Summary
Health-care Applications
Active postmarketing drug surveillance. There is substantial interest within the U.S. health community and among health policymakers in developing a surveillance system that scans public health databases in order to proactively detect potential drug safety... View Details
- 27 Aug 2013
- First Look
First Look: August 27
Factory Models for Cancer Care This case compares and contrasts four different models for delivering View Details
Keywords: Sean Silverthorne
- 27 Sep 2011
- First Look
First Look: September 27
the salience of information is a central determinant of a firm's demand function, even for purchases as large as college attendance. Download the paper: http://www.hbs.edu/research/pdf/12-014.pdf Measuring Teamwork in Health View Details
Keywords: Sean Silverthorne
- 05 Oct 2009
- Research & Ideas
The Vanguard Corporation
striking. It shows the trust and respect these companies have for their people. By giving staff certain goals they need to meet, as well as work on teams that may cut across many parts of the business, employees are motivated very... View Details
Keywords: by Sean Silverthorne
- 11 May 2009
- Research & Ideas
The IT Leader’s Hero Quest
Rising star Jim Barton has decidedly mixed feelings after being selected as the new chief information officer at the fictional IVK Corporation. On the one hand, he lacks an IT background; on the other, he's ambitious and up for a... View Details
Keywords: by Martha Lagace
- Web
Faculty & Advisors | MBA
Technology Chris leads MPM Capital’s public market investing as portfolio manager for BioImpact Equities (formerly known as Burrage Capital) and the Oncology Impact Funds. Previously, Chris was a health care... View Details
- Web
Hiring Organizations
Environmental Defense Fund Epiq Erewhon Estee Lauder Companies, The Eventide Asset Management Evercore EverMetal Exowatt Expedia Group ExxonMobil EY-Parthenon F F-Prime Capital Factorial Energy Fairo Fairstead Fanatics Feltin Community... View Details
- 09 Jan 2018
- First Look
First Look at New Research and Ideas, January 9, 2018
multidisciplinary treatment of head and neck cancers. Methods: Four prospective treatment-based bundles were developed for patients with selected head and neck cancers. These risk-adjusted bundles covered 1 year of View Details
Keywords: Sean Silverthorne